Osteopontin induces growth of metastatic tumors in a preclinical model of non-small lung cancer
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1756-9966
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Osteopontin induces growth of metastatic tumors in a preclinical model of non-small lung cancer ; volume:31 ; number:1 ; day:23 ; month:3 ; year:2012 ; pages:1-12 ; date:12.2012
Journal of experimental & clinical cancer research ; 31, Heft 1 (23.3.2012), 1-12, 12.2012
- Creator
-
Shojaei, Farbod
Scott, Nathan
Kang, Xiaolin
Lappin, Patrick B.
Fitzgerald, Amanda A.
Karlicek, Shannon
Simmons, Brett H.
Wu, Aidong
Lee, Joseph H.
Bergqvist, Simon
Kraynov, Eugenia
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/1756-9966-31-26
- URN
-
urn:nbn:de:101:1-2019080100032807720167
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:36 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Shojaei, Farbod
- Scott, Nathan
- Kang, Xiaolin
- Lappin, Patrick B.
- Fitzgerald, Amanda A.
- Karlicek, Shannon
- Simmons, Brett H.
- Wu, Aidong
- Lee, Joseph H.
- Bergqvist, Simon
- Kraynov, Eugenia
- SpringerLink (Online service)
Other Objects (12)
Osteopontin is a prognostic biomarker in non-small cell lung cancer
Expression of S100A4, ephrin-A1 and osteopontin in non-small cell lung cancer
Mechanisms of osteopontin and CD44 as metastatic principles in prostate cancer cells
Management of Metastatic Nonsmall Cell Lung Cancer in Elderly
Expression of osteopontin-5 splice variant in the mouse primary and metastatic breast cancer cells
Development of fragment-specific osteopontin antibodies and ELISA for quantification in human metastatic breast cancer
The effect of osteopontin and osteopontin-derived peptides on preterm brain injury
NHS-IL2 combined with radiotherapy: preclinical rationale and phase Ib trial results in metastatic non-small cell lung cancer following first-line chemotherapy
JNK signaling in breast cancer cells induces osteopontin and tenascin-C that promote therapy-resistant metastasis
White matter injury but not germinal matrix hemorrhage induces elevated osteopontin expression in human preterm brains
Enhanced osteopontin splicing regulated by RUNX2 is HDAC-dependent and induces invasive phenotypes in NSCLC cells
Osteopontin, osteoprotegerin and musculoskeletal ultrasound findings in first-degree relatives of rheumatoid arthritis: potential markers of preclinical disease
Osteopontin is a prognostic biomarker in non-small cell lung cancer
Expression of S100A4, ephrin-A1 and osteopontin in non-small cell lung cancer
Mechanisms of osteopontin and CD44 as metastatic principles in prostate cancer cells
Management of Metastatic Nonsmall Cell Lung Cancer in Elderly
Expression of osteopontin-5 splice variant in the mouse primary and metastatic breast cancer cells
Development of fragment-specific osteopontin antibodies and ELISA for quantification in human metastatic breast cancer
The effect of osteopontin and osteopontin-derived peptides on preterm brain injury
NHS-IL2 combined with radiotherapy: preclinical rationale and phase Ib trial results in metastatic non-small cell lung cancer following first-line chemotherapy
JNK signaling in breast cancer cells induces osteopontin and tenascin-C that promote therapy-resistant metastasis
White matter injury but not germinal matrix hemorrhage induces elevated osteopontin expression in human preterm brains
Enhanced osteopontin splicing regulated by RUNX2 is HDAC-dependent and induces invasive phenotypes in NSCLC cells
Osteopontin, osteoprotegerin and musculoskeletal ultrasound findings in first-degree relatives of rheumatoid arthritis: potential markers of preclinical disease
Osteopontin is a prognostic biomarker in non-small cell lung cancer
Expression of S100A4, ephrin-A1 and osteopontin in non-small cell lung cancer
Mechanisms of osteopontin and CD44 as metastatic principles in prostate cancer cells
Management of Metastatic Nonsmall Cell Lung Cancer in Elderly
Expression of osteopontin-5 splice variant in the mouse primary and metastatic breast cancer cells
Development of fragment-specific osteopontin antibodies and ELISA for quantification in human metastatic breast cancer
The effect of osteopontin and osteopontin-derived peptides on preterm brain injury
NHS-IL2 combined with radiotherapy: preclinical rationale and phase Ib trial results in metastatic non-small cell lung cancer following first-line chemotherapy
JNK signaling in breast cancer cells induces osteopontin and tenascin-C that promote therapy-resistant metastasis
White matter injury but not germinal matrix hemorrhage induces elevated osteopontin expression in human preterm brains
Enhanced osteopontin splicing regulated by RUNX2 is HDAC-dependent and induces invasive phenotypes in NSCLC cells